Genitourinary Cancer

Disease Group

Genitourinary Cancer

Disease Group Profile

ACCRU serves investigators with innovative ideas that have the potential to raise the standard of care for patients with one of the genitourinary diseases. This includes diseases related to the urinary and genital organs.

Disease Group Leaders

Alan Bryce, M.D.

Mayo Clinic Arizona

Alan Bryce, M.D. is a medical oncologist and clinical trialist focused on prostate cancer.

Tian Zhang, M.D.

UT Southwestern Medical Center

Tian Zhang, M.D. received her M.D. from the Harvard-MIT Health Sciences and Technology (HST) program at Harvard Medical School and completed post-graduate training at Duke University, where she remained on faculty until 2021. She is now Associate Professor within the Division of Hematology and Oncology and Department of Internal Medicine at University of Texas Southwestern Medical Center and leads the multi-disease and precision oncology program within the Harold C. Simmons Comprehensive Cancer Center. Clinically she specializes in genitourinary malignancies. She participates actively in the cooperative group setting and currently serves as co-chair of the NCI GU Steering Committee Renal Task Force. She is a clinical researcher focused on improving novel therapies and biomarkers for patients with renal, prostate, and urothelial cancers.

Disease Group Clinical Trials